Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura C Coates

Showing results (271-280 of 343) with videos related to

Pageof 35
Sort By:
JMIR Research Protocols|August 15, 2025
Effects of Acute Time-Restricted Eating on Inflammation in Individuals With Psoriasis: Protocol for a Case-Control, Prospective StudySinibaldo Romero Arocha, Kim Han, Rebecca D Huffstutler, et al.
The Journal of Rheumatology. Supplement|June 3, 2020
GRAPPA 2019 Project ReportNiti Goel, Laura C Coates, Gabriele De Marco, et al.
The Journal of Rheumatology|May 3, 2016
Let's Talk about Inclusion: A Report on Patient Research Partner Involvement in the GRAPPA 2015 Annual MeetingMaarten de Wit, Willemina Campbell, Laura C Coates, et al.
Rheumatology Advances in Practice|February 5, 2021
Systematic literature review of non-topical treatments for early, untreated (systemic therapy naïve) psoriatic disease: a GRAPPA initiativeGabriele De Marco, Anna Berekméri, Laura C Coates, et al.
Rheumatology (Oxford, England)|March 16, 2026
Bimekizumab safety and efficacy in patients with psoriatic arthritis: 3-year results from two phase 3 studiesLaure Gossec, Laura C Coates, Robert B M Landewé, et al.
The Journal of Rheumatology|April 16, 2021
Test-retest Reliability for HAQ-DI and SF-36 PF for the Measurement of Physical Function in Psoriatic ArthritisYing Ying Leung, William Tillett, Pil Hojgaard, et al.
Rheumatology (Oxford, England)|September 1, 2020
Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritisLaura C Coates, Joseph F Merola, Philip J Mease, et al.
Rheumatology (Oxford, England)|December 20, 2024
Psoriatic Arthritis Priority Setting Partnership: patient- and clinician-informed considerations for future UK health service deliveryLija James, Louise Hailey, Christine Bundy, et al.
Rheumatology (Oxford, England)|June 29, 2022
Guselkumab provides sustained domain-specific and comprehensive efficacy using composite indices in patients with active psoriatic arthritisLaura C Coates, Christopher T Ritchlin, Laure Gossec, et al.
Drug Safety|October 31, 2023
Long-Term Safety of Guselkumab in Patients with Psoriatic Disease: An Integrated Analysis of Eleven Phase II/III Clinical Studies in Psoriasis and Psoriatic ArthritisBruce Strober, Laura C Coates, Mark G Lebwohl, et al.
Pageof 35

Showing results (271-280 of 343) with videos related to

Sort By:
Pageof 35
JMIR Research Protocols|August 15, 2025
Effects of Acute Time-Restricted Eating on Inflammation in Individuals With Psoriasis: Protocol for a Case-Control, Prospective StudySinibaldo Romero Arocha, Kim Han, Rebecca D Huffstutler, et al.
The Journal of Rheumatology. Supplement|June 3, 2020
GRAPPA 2019 Project ReportNiti Goel, Laura C Coates, Gabriele De Marco, et al.
The Journal of Rheumatology|May 3, 2016
Let's Talk about Inclusion: A Report on Patient Research Partner Involvement in the GRAPPA 2015 Annual MeetingMaarten de Wit, Willemina Campbell, Laura C Coates, et al.
Rheumatology Advances in Practice|February 5, 2021
Systematic literature review of non-topical treatments for early, untreated (systemic therapy naïve) psoriatic disease: a GRAPPA initiativeGabriele De Marco, Anna Berekméri, Laura C Coates, et al.
Rheumatology (Oxford, England)|March 16, 2026
Bimekizumab safety and efficacy in patients with psoriatic arthritis: 3-year results from two phase 3 studiesLaure Gossec, Laura C Coates, Robert B M Landewé, et al.
The Journal of Rheumatology|April 16, 2021
Test-retest Reliability for HAQ-DI and SF-36 PF for the Measurement of Physical Function in Psoriatic ArthritisYing Ying Leung, William Tillett, Pil Hojgaard, et al.
Rheumatology (Oxford, England)|September 1, 2020
Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritisLaura C Coates, Joseph F Merola, Philip J Mease, et al.
Rheumatology (Oxford, England)|December 20, 2024
Psoriatic Arthritis Priority Setting Partnership: patient- and clinician-informed considerations for future UK health service deliveryLija James, Louise Hailey, Christine Bundy, et al.
Rheumatology (Oxford, England)|June 29, 2022
Guselkumab provides sustained domain-specific and comprehensive efficacy using composite indices in patients with active psoriatic arthritisLaura C Coates, Christopher T Ritchlin, Laure Gossec, et al.
Drug Safety|October 31, 2023
Long-Term Safety of Guselkumab in Patients with Psoriatic Disease: An Integrated Analysis of Eleven Phase II/III Clinical Studies in Psoriasis and Psoriatic ArthritisBruce Strober, Laura C Coates, Mark G Lebwohl, et al.
Pageof 35